Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

histiocytoma/тошнота

Ссылка сохраняется в буфер обмена
СтатьиКлинические испытанияПатенты
Страница 1 от 17 полученные результаты

[A case of malignant fibrous histiocytoma treated with intraarterial chemotherapy under complete venous isolation and charcoal hemoperfusion].

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Herein reported is a case with malignant fibrous histiocytoma (MFH) at the left elbow treated successfully with intraarterial chemotherapy under complete brachial venous isolation and charcoal hemoperfusion (BVI-CHP). A 56-year-old man was admitted to our institution because of local recurrence at

Benign fibrous histiocytoma of the stomach: report of a case.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
We report herein an extremely very rare case of primary benign fibrous histiocytoma of the stomach found in a 56-year-old man who presented with a 2-week history of nausea and anorexia. Gastrointestinal X-rays and endoscopy revealed a protruding lesion in the stomach, but biopsies failed to

Brain metastasis from malignant fibrous histiocytoma of the heart: case report.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
This is the second reported case of a malignant fibrous histiocytoma of the heart that metastasized to the brain. A 33-year-old woman developed headache, nausea, and ataxic gait 9 months after removal of the tumor from the left atrium of the heart. Computed tomographic and magnetic resonance imaging

A primary malignant fibrous histiocytoma of the scalp and intracranial tumor bleeding: a case report.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND A malignant fibrous histiocytoma occurring on the scalp near a primary operation site is extremely rare. METHODS A 74-year-old Chinese man presented with a one-month history of recurrent headaches, vomiting and left limb atony. He had undergone a successful clipping operation through the

[Combination chemotherapy with vincristin, actinomycin D, cyclophosphamide and adriamycin in soft-part sarcoma].

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Fifteen patients with soft-part sarcoma were treated with combination chemotherapy consisting of vincristin, actinomycin D, cyclophosphamide and adriamycin (VACA therapy). The cumulative five-year survival rate by the Kaplan-Meier method was about 73%. This VACA therapy was effective for malignant

A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomas.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
One-hundred-fourteen evaluable patients with metastatic soft tissue or bony sarcoma with measurable disease were treated with Adriamycin (doxorubicin) administered intravenously at a dose of 60 mg/M2 on day 1, followed by DTIC (dacarbazine) at a dose of 750 mg/M2; courses were administered at 3-week

[The clinical phase I study of TNP-351. The TNP-351 Research Committee].

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
The clinical phase I study of TNP-351, an antifolate drug having a novel structure, was performed through a multicenter cooperative program in 40 patients with solid tumors. The test drug was used on dosage schedules of single and daily doses for 5 or 3 days (by intravenous drip over 30 minutes,

[Two cases of the middle fossa tumor following radiotherapy against retinoblastoma].

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Two cases of brain tumors which developed after radiotherapy against retinoblastomas are reported. A 17-year-old girl was admitted with a chief complaint of swelling in her forehead after head injury in July, 1981. At 7 months old her left eye had been enucleated and she had received radiation

A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U).

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Thirty-eight patients with advanced resistant cancers were enrolled on this study of piritrexim (PTX; BW 301U) administered intravenously weekly for 4 weeks. Of 50 courses of treatment begun, 39 evaluable 4-week courses of the drug were completed by this group of patients. Dosages ranged from 44 to

Human pharmacological investigation of a human recombinant tumor necrosis factor preparation (PAC-4D) a phase-I trial.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
15 patients aged between 24 and 66 years with 10 different malignant tumor diseases were treated with a recombinant human tumor necrosis factor preparation PAC-4D in a phase-I trial. The starting dose was 10(5) U PAC-4D as an intravenous short infusion. The maximally tolerable dose is around 18 X

Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Sarcoma: A Multicenter, Retrospective Study.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
To evaluate the efficacy and safety of nanosomal docetaxel lipid suspension (NDLS, DoceAqualip) based chemotherapy in patients with sarcoma.

Methods
In this retrospective, multicenter (6 centers), observational study, we analyzed the medical charts of

A phase II study of intravenously- administered methyl CCNU in the treatment of advanced sarcomas.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Thirty-two patients with advanced, inoperable nonhematologic soft-tissue and osseous sarcomas were treated with Methyl CCNU administered via controlled intravenous infusion in doses of 130-170 mg/m2 every 6 weeks in a Phase II trial. All 28 evaluable patients were no longer responsive to adriamycin.

EORTC Group Phase II Study of Oral Etoposide for Pretreated Soft Tissue Sarcoma.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Purpose. This study investigates the efficacy and toxicity of daily oral etoposide in chemotherapy for non-heavily pretreated advanced and metastatic soft tissue sarcoma (STS).Subjects. Twenty-seven patients with progressive and measurable disease were treated. Median age was 53 years (range 20-71

[Primary retroperitoneal tumors. Our experience].

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Primary retroperitoneal tumors are rare (0.05-0.2% of all tumors), often malignant and characterized by a poor and non-specific symptomatology and by a late diagnosis. Complete resection is possible in only a few patients, while recurrence is very common. The records of 29 adult patients who

Phase II study of recombinant alfa-2a interferon in patients with advanced bone sarcomas.

Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
Twenty previously treated patients with advanced bone sarcomas received thrice weekly im 50 X 10(6) IU/m2 doses of human alfa-interferon (interferon alfa-2a, recombinant; Roche). Seventeen patients had metastatic osteosarcomas and one each had fibrosarcoma, mesenchymal chondrosarcoma, and malignant
Присоединяйтесь к нашей
странице facebook

Самая полная база данных о лекарственных травах, подтвержденная наукой

  • Работает на 55 языках
  • Травяные лекарства, подтвержденные наукой
  • Распознавание трав по изображению
  • Интерактивная карта GPS - отметьте травы на месте (скоро)
  • Прочтите научные публикации, связанные с вашим поиском
  • Ищите лекарственные травы по их действию
  • Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов

Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.

Google Play badgeApp Store badge